Advertisement

Topics

Mylan Receives Tentative Approval for "TLE400" Under PEPFAR

09:26 EDT 20 Mar 2017 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
HERTFORDSHIRE, England and PITTSBURGH, March 20, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL), a leading global pharmaceutical company, today announced receipt of tentative approval from the U.S. Food and Drug Administration under the U.S. President...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Mylan Receives Tentative Approval for "TLE400" Under PEPFAR"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Reverse Transcriptase
Reverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. It is mainly associated with retroviruses. RT inhibitors are widely used as antiretroviral drugs. RT activitie...